MC1R variant alleles and malignant melanoma risk in Israel

European Journal of Cancer

Volumn 45, Issue 11, 2009, Pages 2015-2022

  Galore Haskel, Gilli ^a   Azizi, Esther ^b   Mohamdi, Hamida ^c   Scope, Alon ^d   Chaudru, Valérie ^c   Laitman, Yael ^a   Barak, Frida ^e   Pavlotsky, Felix ^b   Demenais, Florence ^c   Friedman, Eitan ^a  

^a GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c FONDATION JEAN DAUSSET CEPH   (France)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e Barzilai Hospital   (Israel)

Author keywords

Ashkenazi Jews; Malignant melanoma risk; MC1R; Sequence variants

Indexed keywords

MELANOCORTIN 1 RECEPTOR;

ADULT; ALLELE; ARTICLE; CANCER PATIENT; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; DEMOGRAPHY; DNA EXTRACTION; ETHNIC AND RACIAL GROUPS; ETHNIC DIFFERENCE; FAMILY HISTORY; FEMALE; GENE SEQUENCE; GENETIC CODE; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERVIEW; ISRAEL; MAJOR CLINICAL STUDY; MELANOMA; NUCLEOTIDE SEQUENCE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN VARIANT; QUESTIONNAIRE;

ADULT; AGE OF ONSET; BASE SEQUENCE; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; ISRAEL; JEWS; MALE; MELANOMA; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 1; RISK;

EID: 67649365613     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.02.001     Document Type: Article

References (31)

1. Tucker M.A., and Goldstein A.M. Melanoma etiology: where are we?. Oncogene 22 (2003) 3042-3052
2. Israel Ministry of Health, Israel National Cancer Registry; 2006.
3. Hayward N.K. Genetics of melanoma predisposition. Oncogene 22 (2003) 3053-3062
4. Hussussian C.J., Struewing J.P., Goldstein A.M., et al. Germline p16 mutations in familial melanoma. Nat Genet 8 (1994) 15-21
5. Goldstein A.M., Chan M., Harland M., et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 66 (2006) 9818-9828
6. Zuo L., Weger J., Yang Q., et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 12 (1996) 97-99
7. Soufir N., Avril M.F., Chompret A., et al. Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group. Human Mol Genet 7 (1998) 209-216
8. Molven A., Grimstvedt M.B., Steine S.J., et al. A large Norwegian family with inherited malignant melanoma, multiple atypical nevi, and CDK4 mutation. Genes Chromosomes Cancer 44 (2005) 10-18
9. Yakobson E., Shemesh P., Azizi E., et al. Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families. Eur J Human Genet 8 (2000) 590-596
10. Loo J.C., Paterson A.D., Hao A., et al. Search for genetic variants associated with cutaneous malignant melanoma in the Ashkenazi Jewish population. J Med Genet 42 (2005) e30
11. Marian C., Scope A., Laud K., et al. Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours. Brit J Cancer 92 (2005) 2278-2285
12. Brown K.M., Macgregor S., Montgomery G.W., et al. Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet 40 (2008) 838-840
13. Gudbjartsson D.F., Sulem P., Stacey S.N., et al. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat Genet 40 (2008) 886-891
14. Valverde P., Healy E., Jackson I., Rees J.L., and Thody A.J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nat Genet 11 (1995) 328-330
15. Barsh G.S. The genetics of pigmentation: from fancy genes to complex traits. Trends Genet 12 (1996) 299-305
16. Chhajlani V., and Wikberg J.E. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 309 (1992) 417-420
17. Abdel-Malek Z., Scott M.C., Suzuki I., et al. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res 13 (2000) 156-162
18. Wong T.H., and Rees J.L. The relation between melanocortin-1 receptor (MC1R) variation and the generation of phenotypic diversity in the cutaneous response to ultraviolet radiation. Peptides 26 (2005) 1965-1971
19. Bastiaens M., ter Huurne J., Gruis N., et al. The melanocortin-1-receptor gene is the major freckle gene. Human Mol Genet 10 (2001) 1701-1708
20. Palmer J.S., Duffy D.L., Box N.F., et al. Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?. Am J Human Genet 66 (2000) 176-186
21. van der Velden P.A., Sandkuijl L.A., Bergman W., et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Human Genet 69 (2001) 774-779
22. Matichard E., Verpillat P., Meziani R., et al. Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41 (2004) e13
23. Landi M.T., Kanetsky P.A., Tsang S., et al. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 97 (2005) 998-1007
24. Stratigos A.J., Dimisianos G., Nikolaou V., et al. Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 126 (2006) 1842-1849
25. Bastiaens M.T., ter Huurne J.A., Kielich C., et al. Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair. Am J Human Genet 68 (2001) 884-894
26. Makova K., and Norton H. Worldwide polymorphism at the MC1R locus and normal pigmentation variation in humans. Peptides 26 (2005) 2901-2908
27. Gerstenblith M.R., Goldstein A.M., Fargnoli M.C., Peris K., and Landi M.T. Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Human Mutat 28 (2007) 495-505
28. Beaumont K.A., Shekar S.N., Newton R.A., et al. Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Human Mol Genet 16 (2007) 2249-2260
29. Raimondi S., Sera F., Gandini S., et al. MC1R variants, melanoma and red hair color phenotype: a meta-analysis. Int J Cancer 122 (2008) 2753-2760
30. Schioth H.B., Phillips S.R., Rudzish R., Birch-Machin M.A., Wikberg J.E., and Rees J.L. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 260 (1999) 488-491
31. Goldstein A.M., Landi M.T., Tsang S., Fraser M.C., et al. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomark Prev 14 (2005) 2208-2212